The aim of this study was to evaluate the chemical composition and antimicrobial activity of four unexplored Eugenia species: Eugenia brevistyla, Eugenia handroana, Eugenia catharinae and Eugenia stigmatosa. Eight extracts and eighteen fractions were screened for their antibacterial activity against some selected bacteria including Mycoplasma. Phytochemical screening revealed that the plants were rich in terpenes and phenolic compounds. Antimicrobial evaluation revealed that E. handroana (FAEF-EH) and E. brevistyla (FAEF-EB) had the highest activity against Staphylococcus aureus with minimum inhibitory concentration (MIC) of 15.62 µg/ml Mycoplasma while FAEF-EH also presented the best activity with MIC of 62.5 µg/ml against Mycoplasma pneumonia M129. Some isolated compounds, betulinic acid and glutinol, also exhibited antibacterial property against some bacteria used in the study. All the four species studied presented promising antibacterial activity while the active principles are yet to be elucidated.
INTRODUCTION
The plants of the Eugenia genus (Myrtaceae) are widely distributed in tropical and subtropical regions (Fischer et al., 2005; Zaki et al., 2013) . They are known for their tasty fruits, and include some Brazilian plants as Eugenia uniflora ("Pitanga"), Eugenia involucrata ("Cereja-domato"), Eugenia jambolona ("jambolão") and Eugenia edulis ("jaboticaba") . This genus comprises a large group of medicinal plants with therapeutic applications of their different medicinal properties, such as anti-inflammatory, hypoglycemic, diuretic, analgesic, antidiarrheal, antirheumatic, antibacterial, protection against stomach disorders, etc (Saha et al., 2002; Auricchio and Bacchi, 2003; Bag et al., 2012; Victoria et al., 2012; Famuyiwa and Adebajo, 2012; Garmus et al., 2014) . Infections caused by numerous microorganisms are a constant public health problem, and bacterial infections are responsible for several diseases such as pneumonia, meningitis, and endocarditis (Souza et al., 2004) . Infections caused by resistant microorganisms and those caused by "commensal" microorganisms, are increasing every year (Muraina et al., 2009) . Mycoplasmas are bacteria that belong to the class Mycoplasma, and cause respiratory and urogenital diseases in human beings (Muraina et al., 2009) . They are the smallest microorganisms that are capable of self-replication, lacking a cell wall and presenting variable susceptibility to antibiotics (Murray, 2007) .
Considering the chemotaxonomy and the important activities already described for the Eugenia genus, the reported increase in antibiotic resistance, as well as the increase in infections caused by Mycoplasma, four Brazilian plants of the Eugenia species E. brevistyla, E. handroana, E. catharinae and E. stigmatosa have been evaluated for their chemical compositions and antimicrobial activity against selected bacteria including Mycoplasma.
MATERIALS AND METHODS

Plant material
The place and season (year) of collection of each species are shown in Table 1 .
Phytochemical analyses
Extraction procedures
Leaves (760 g) and stems (495 g) of E. brevistyla; leaves (2056 g) and stems (980 g) of E. handroana; leaves (785 g) and stems (104 g) of E. catharinae and leaves (295 g) and stems (150 g) of E. stigmatosa were extracted separately by macerating in methanol for 7 days at room temperature. The solutions were then filtered and concentrated in a rotary evaporator under reduced pressure (50°C), furnishing the respective methanolic extracts. All the obtained extracts were successively partitioned with solvents of different polarities (dichloromethane or chloroform and ethyl acetate) to obtain the respective fractions (FDCM or FCHCl3 and FAE) . All the yields are shown in Table 2 .
Isolation of the chemical constituents
In order to isolate the major compounds, all the fractions were separately subjected to open silica gel column chromatography (CC) eluted with hexane: ethyl acetate gradient. Thin layer chromatography, used to monitor purity, was carried out on a precoated Merck Kieselgel 60 F254 plate (0.25 mm) eluted with hexane: ethyl acetate gradient and the spots were compared with the standards. The compounds were identified by conventional spectral data (NMR, IR, MS) and compared with standard samples and the literature. In some cases, the compounds were subjected to gas mass spectrometry (GC/MS) to confirm their identities. The isolated compounds and the yields are shown in Table 3 . The molecular structures are shown in Figure 1 . The RMN spectral dates were: .1 (C16), 26.9 (C15), 27.2 (C2), 28.1 (C23); 28.4 (C28), 31.0 (C20), 32.4 (7), 32.6 (C17), 33.3 (C29), 34.7 (C21), 36.9 (C10), 37.1 (C22), 38.5 (C4), 38.7 (C1), 39.8 (C8), 41.7 (C14), 46.8 (C19), 47.2 (C18), 47.6 (C9), 55.1 (C5), 79.0 (C3), 121.3 (C12), 145.2 (C13). The mixture of α-β amyrin was submitted to GC-MS, indicating the presence of 90% of β-amyrin and 10% of α-amyrin.
Nerolidol: Nerolidol, being an oil was identified by liquid chromatography coupled to mass spectrometry. The fragmentation with compound was characteristic of Nerolidol, with base peak 69 m/z and molecular ion of 204 m/z. 
Biological activity
Antimycoplasma activity
The antimollicute assays were collected from the Laboratory of Clinical Microbiology from FURB that provided the bacterial strains. Tests were evaluated against mollicutes strains (no-cell-wall bacteria) Mycoplasma mycoides subsp. capri (NCTC 10137 (Velleca et al., 1980) .
The crude extracts and fractions from E. handroana, E. brevistyla, E. catharinae and E. stigmatosa were evaluated by determination of the minimum inhibitory concentration (MIC). The microdilution broth assay was performed in sterile 96-well microplates, as recommended by the Clinical and Laboratory Standards Institute (CLSI, 2012) for cell-wall bacteria and Bebear and Roberteson (1996) for mollicutes.
The samples were properly prepared and transferred to each microplate well with the appropriate culture medium, in order to obtain a two-fold serial dilution of the original extract in a 10% medium/dimethyl sulfoxide (DMSO) solution, obtaining sample concentrations ranging between 1000 to 7.81 μg.mL -1 . The inoculum containing 10 4 to 10 5 microorganisms per ml were then added to each well. A number of wells were reserved in each plate to test for sterility control (no inoculum added), positive control (gentamycin or ciprofloxacin), inoculum viability (no extract added), and the DMSO inhibitory effect. The microplates were incubated at 37°C ± 1°C for 24 or 48 h (depending on the bacterium). Thereafter, growth of mollicutes strains was detected by observing the colour change in the medium. The MIC was defined as the lowest concentration of the samples able to inhibit bacterial growth.
Antibacterial activity with cell wall bacterial and fungal
The antibacterial assays were conducted at the Laboratory of Clinical Microbiology from UNIVALI that provided the bacterial strains. The determination of the minimum inhibitory concentration (MIC) was performed by broth microdilution. The method consisted in preparing successive dilutions of the tested extracts (1000 µg/mL up to 2 µg/mL) in culture media Mueller-Hinton broth for the bacteria (Staphylococcus aureus and Escherichia coli) and Sabouraud broth for the yeast (Candida albicans). The media were inoculated with the microorganism under study, incubated and later verified the lowest concentration that inhibited its growth.
RESULTS AND DISCUSSION
Chromatographic fractionation of leaves and stems fractions of the four studied plants led to isolation and identification of the compounds shown in Tables 2 and 3 . For the evaluation of the antibacterial activity, a criterion established by Holetz et al. (2002) was used. Samples with MIC values lower than 10 μg ml -1 were considered to have excellent antibacterial activity; between 10 and 100 μg ml -1 were considered good; values between 100 and 500 μg ml -1 were considered to be of moderate activity; values between 500 and 1000 μg ml -1 of low activity, and for MIC values higher than 1000 μg ml -1 , samples were considered inactive for the extracts and fractions. The isolated compounds were considered inactive with MIC higher than 100 μg ml -1
. The results for MIC of all the samples are shown in Table 4 (Mycoplasma strains) and Table 5 (cell wall bacterial and fungal strains).
Of all samples tested, the highest activity was observed against Staphylococcus aureus. S. aureus, a Grampositive bacterium is responsible for a large number of infections ranging from simple infections, such as acne or cellulitis to severe infections like pneumonia, meningitis, endocarditis, toxic shock syndrome, and sepsis. This is particularly true for the infections caused by methicillinresistant S. aureus (MRSA), which is most often resistant to multiple antibiotic classes and is responsible for the majority of infections (Boucher et al., 2010; Lin et al., 2013; Bolt et al., 2017) .
The FAE-F of E. handroana (FAEF-EH) and the FAE-F of E. brevistyla (FAEF-EB) exhibited pronounced ). The results observed for E. handroana and E. brevistyla were the most promising. Antibacterial activity against S. aureus by other species of Eugenia such as E. caryophyllata and E. brasiliensis had been reported (Magina et al., 2012; Prakash et al., 2012) . It is interesting to note that the fractions with higher polarity (ethyl acetate) showed better activity. On the other hand, the Gram-negative bacteria such as E. coli were not sensitive to the extracts and fractions until 1000 μg ml -1 . Antifungal evaluation against Candida albicans showed that the extract and fractions from the stem of E. stigmatosa had the best activity with MIC of 125 μg ml -1 for the EBM-C and 250 μg ml -1 for FAEC-ES. The EMBC of E. catharinae also inhibited fungal growth at MIC = 250 μg ml -1. Some Eugenia species as E. calycina (Ferreira et al., 2014) , E. caryophyllata (Mansourian et al., 2014) , and E. jambolana (Satish et al., 2008) have been reported to have antifungal activity.
Among the tested samples, the highest activity against the Mycoplasma was observed in the FAEF-EH fraction against M. pneumoniae M129 (62.5 µg ml -1 ). However, despite this pronounced activity, for the other species of Mycoplasma, the samples that presented the best activity were nonpolar fractions. FCHCl 3 F-EB and FDCMC-EC showed MIC of 125 µg ml -1 against some samples tested. It is likely that highest presence of nonpolar compounds such as fatty acids and triterpenes in high quantity favored the action against the Mycoplasma strains.
Previous study by Tenfen et al. (2017) has attributed antimycoplasma activity of E. platysema to the presence of triterpenes. Another study by Zatelli et al. (2015) attributed anti-Mycoplasma activity of E. hiemalis to the essential oil component of the species. The isolated compounds in this study such as nerolidol (3) and the mixture of α,β amyrin (1,2) were inactive against the Mycoplasma strains. On the other hand, the compounds betulinic acid (4) and glutinol (5) showed encouraging activity against some strains tested.
Betulinic acid (4), was considered inactive against strains of S. aureus, E. coli and C. albicans (MIC > 128 µg ml -1 ) (Woldemichae et al., 2003) , and considered active against some strains of Mycoplasma tested in this study, especially against M. pneumoniae FH, with MIC of humans (Boucher et al., 2010; Cordova et al., 2010) . Reports of resistance of cell wall bacteria and Mycoplasma to conventional treatments have also increased (Yechouron et al., 1992; Ma et al., 2017) and studies are in progress to determine other active principles present in the most promising species such as E. brevistyla and E. handroana.
